» Articles » PMID: 10829942

Chronic Viral Hepatitis

Overview
Specialty Pediatrics
Date 1995 Nov 1
PMID 10829942
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Among hepatitis A to E viruses, hepatitis B, C, and D viruses can cause chronic hepatitis, in both children and adults. Hepatitis B virus (HBV) infection is the most prevalent and important one. Perinatal transmission accounts for about 40-45% of chronic HBV infection in hyperendemic areas. Horizontal transmission through intramuscular injection using non-sterile needles and intrafamilial spread accounts for the other half of carriers. During the natural course of HBV infection, the host gradually clears HBV and hepatitis B e antigen (HBeAg), liver damage and elevation of aminotransferases occur during the process of HBV clearance. The most effective way to eliminate HBV infection is immunoprophylaxis starting since birth. It can prevent both HBV and hepatitis D virus (HDV) infections. Hepatitis C virus (HCV) infection in children occurs mainly in high risk children, such as those who received blood product or injection using non-sterile needles, or infants of HCV viremic mothers, etc. Screening of blood product reduced markedly the prevalence of post-transfusion HCV infection, but the prevention of sporadic cases requires HCV vaccination which is still under investigation.

Citing Articles

NLRP3 inflammasome activation contributes to acute liver injury caused by CVA6 infection in mice.

Xie Y, Hu Q, Duan G, Wang F, Feng F, Li D BMC Infect Dis. 2024; 24(1):1251.

PMID: 39501208 PMC: 11539563. DOI: 10.1186/s12879-024-10136-2.

References
1.
Hsu H, Chang M, Chen D, Lee C, SUNG J . Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol. 1986; 18(4):301-7. DOI: 10.1002/jmv.1890180402. View

2.
Beasley R, Hwang L, Lin C, Stevens C, Wang K, Sun T . Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet. 1981; 2(8243):388-93. DOI: 10.1016/s0140-6736(81)90832-1. View

3.
Beasley R, Hwang L . Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis. 1983; 147(2):185-90. DOI: 10.1093/infdis/147.2.185. View

4.
Bhattacharya D, Bhattacharjee S, De M, Lahiri P . Prevalence of hepatitis C in transfusion dependent thalassaemics & haemophilics. Indian J Med Res. 1991; 94:430-2. View

5.
Hsu H, Chang M, Hsieh K, Lee C, Lin H, Hwang L . Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology. 1992; 15(5):770-6. DOI: 10.1002/hep.1840150505. View